Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 13/20 | 0.56 |
| ▸ | UBE2M | P61081 | 3/20 | 0.41 |
| ▸ | DCUN1D1 | Q96GG9 | 3/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3324161 | 1.00 | EPHX2 (0.56) | EPHX2UBE2MDCUN1D1PTGS1PTGS2 | |
| SCHEMBL3324162 | 1.00 | EPHX2 (0.56) | EPHX2UBE2MDCUN1D1PTGS1PTGS2 | |
| SCHEMBL3325308 | 0.90 | EPHX2 (0.60) | EPHX2PTGS1PTGS2MAPK1 | |
| SCHEMBL3326649 | 0.90 | EPHX2 (0.60) | EPHX2PTGS1PTGS2MAPK1 | |
| SCHEMBL3325304 | 0.90 | EPHX2 (0.60) | EPHX2PTGS1PTGS2MAPK1 | |
| SCHEMBL3329336 | 0.84 | EPHX2 (0.43) | EPHX2MAPK1KDM4ESMN1; SMN2 | |
| SCHEMBL3329332 | 0.84 | EPHX2 (0.43) | EPHX2MAPK1KDM4ESMN1; SMN2 | |
| SCHEMBL3325713 | 0.80 | EPHX2 (0.55) | EPHX2 | |
| SCHEMBL3326746 | 0.80 | EPHX2 (0.55) | EPHX2 | |
| SCHEMBL3325715 | 0.80 | EPHX2 (0.55) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120769-A1 | CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES | NETTEKOVEN MATTHIAS | 2010-05-13 | — | — | US | disclosed |
| US-20070167436-A1 | Cyclohexyl piperazinyl methanone derivatives | HOFFMANN-LA ROCHE INC. | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120769-A1 | CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES | HRH3, HRH4, HRH1 | EPHX2 3709/4885UBE2M 4773/4885DCUN1D1 4272/4885 |
| US-20070167436-A1 | Cyclohexyl piperazinyl methanone derivatives | HRH3, HRH4, HRH1 | EPHX2 3709/4885UBE2M 4773/4885DCUN1D1 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.